Literature DB >> 7000236

Secondary prevention of myocardial infarction--the present state of the ART.

J R Mitchell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7000236      PMCID: PMC1601166          DOI: 10.1136/bmj.280.6223.1128

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  14 in total

1.  Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets.

Authors:  A GAARDER; J JONSEN; S LALAND; A HELLEM; P A OWREN
Journal:  Nature       Date:  1961-11-11       Impact factor: 49.962

2.  Impaired platelet-connective-tissue reaction in man after aspirin ingestion.

Authors:  H J Weiss; L M Aledort
Journal:  Lancet       Date:  1967-09-02       Impact factor: 79.321

3.  Treatment of the patient after myocardial infarction. The last decade and the next.

Authors:  E Braunwald
Journal:  N Engl J Med       Date:  1980-01-31       Impact factor: 91.245

4.  Effect of dipyridamole on human platelet behaviour.

Authors:  P R Emmons; M J Harrison; A J Honour; J R Mitchell
Journal:  Lancet       Date:  1965-09-25       Impact factor: 79.321

5.  Aspirin and secondary mortality after myocardial infarction.

Authors:  P C Elwood; P M Sweetnam
Journal:  Lancet       Date:  1979 Dec 22-29       Impact factor: 79.321

6.  Effect of a pyrimidopyrimidine derivative on thrombus formation in the rabbit.

Authors:  P R Emmons; M J Harrison; A J Honour; J R Mitchell
Journal:  Nature       Date:  1965-10-16       Impact factor: 49.962

7.  An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation.

Authors:  S Moncada; R Gryglewski; S Bunting; J R Vane
Journal:  Nature       Date:  1976-10-21       Impact factor: 49.962

8.  Aspirin prophylaxis of venous thromboembolism after total hip replacement.

Authors:  W H Harris; E W Salzman; C A Athanasoulis; A C Waltman; R W DeSanctis
Journal:  N Engl J Med       Date:  1977-12-08       Impact factor: 91.245

9.  Uric acid: a risk factor for coronary heart disease?

Authors:  V W Persky; A R Dyer; E Idris-Soven; J Stamler; R B Shekelle; J A Schoenberger; D M Berkson; H A Lindberg
Journal:  Circulation       Date:  1979-05       Impact factor: 29.690

10.  A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction.

Authors:  P C Elwood; A L Cochrane; M L Burr; P M Sweetnam; G Williams; E Welsby; S J Hughes; R Renton
Journal:  Br Med J       Date:  1974-03-09
View more
  8 in total

Review 1.  [Review of plasma anti-aggregants and their indications in primary care. Eight years later].

Authors:  M Blasco Valle; J F Lucía Cuesta
Journal:  Aten Primaria       Date:  2003-03-15       Impact factor: 1.137

2.  Secondary prevention of myocardial infarction: an uncertain feeling.

Authors:  J T Hart; S L Barley
Journal:  J R Coll Gen Pract       Date:  1982-11

Review 3.  "But will it help my patients with myocardial infarction?" The implications of recent trials for everyday country folk.

Authors:  J R Mitchell
Journal:  Br Med J (Clin Res Ed)       Date:  1982-10-23

Review 4.  Timolol after myocardial infarction: an answer or a new set of questions?

Authors:  J R Mitchell
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-16

Review 5.  Prostaglandins in vascular disease: a seminal approach.

Authors:  J R Mitchell
Journal:  Br Med J (Clin Res Ed)       Date:  1981-02-21

6.  Theory and practice in prevention of arterial thrombosis.

Authors:  J R Mitchell
Journal:  Br Heart J       Date:  1982-11

7.  Aspirin and myocardial infarction in young women.

Authors:  L Rosenberg; D Slone; S Shapiro; D W Kaufman; O S Miettinen; P D Stolley
Journal:  Am J Public Health       Date:  1982-04       Impact factor: 9.308

8.  Sulphinpyrazone in acute myocardial infarction: studies on cardiac rhythm and renal function.

Authors:  R G Wilcox; D Richardson; J R Hampton; J R Mitchell; D C Banks
Journal:  Br Med J       Date:  1980-08-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.